Detalles de la búsqueda
1.
ASSESSMENT OF EARLY CHANGES IN SPECTRAL DOMAIN-OPTICAL COHERENCE TOMOGRAPHY AFTER INITIATION OF TREATMENT WITH INTRAVITREAL AFLIBERCEPT (EYLEA) OVER A 12-WEEK PERIOD FOR PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Multicenter French Study (START).
Retina
; 41(3): 588-594, 2021 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33600134
2.
Efficacy and safety of intravitreal aflibercept in ranibizumab-refractory patients with neovascular age-related macular degeneration.
BMC Ophthalmol
; 21(1): 90, 2021 Feb 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33596867
3.
The role of future treatments in the management of neovascular age-related macular degeneration in Europe.
Eur J Ophthalmol
; 31(5): 2179-2188, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34053331
4.
Photodynamic therapy vs limited macular translocation in the management of subfoveal choroidal neovascularization in pathologic myopia: a two-year study.
Am J Ophthalmol
; 143(1): 68-76, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17188042
5.
Assessment of Choroidal Topographic Changes by Swept-Source Optical Coherence Tomography After Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration.
Am J Ophthalmol
; 160(5): 1006-13, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26275471
6.
Assessment of choroidal topographic changes by swept source optical coherence tomography after photodynamic therapy for central serous chorioretinopathy.
Am J Ophthalmol
; 157(4): 852-60, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24412124
Resultados
1 -
7
de 7
1
Próxima >
>>